VivoSeq
Other

Medical Procedure

5

Pipeline Programs↗

1

Active Trials↗

4

Companies Involved↗

Medical Procedure is an early-stage landscape with 5 programs across 4 companies. The most active players are Acacia Pharma Ltd, Pfizer, Hikma Pharmaceuticals LLC. 2 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

0/100

Mech. Concentration

33/100

Completion Rate

67/100

Attrition Rate

25/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Acacia Pharma Ltd

1 program

Phase 3Pfizer logo

Pfizer

1 program

Phase 3H

Hikma Pharmaceuticals LLC

1 program

PreclinicalNovartis logo

Novartis

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

4

clinical trials

Completed2 · 50%
Withdrawn1 · 25%
Active, not recruiting1 · 25%

Clinical Trials

Trial Activity

Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: Trial
Withdrawn·SSt. Justine's Hospital·N/A·NCT02947243
Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation
Completed·Pfizer logoPfizer·Phase 3·NCT01438931·162 enrolled
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
Active, not recruiting·AAcacia Pharma Ltd·Phase 2/3·NCT04851717·100 enrolled
Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications
Completed·UUniversity of Jena·N/A·NCT06251349·512 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)